Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis.

[1]  K. Kim,et al.  Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization versus Portal Vein Embolization Only before Major Hepatectomy for Patients with Hepatocellular Carcinoma , 2011, Annals of Surgical Oncology.

[2]  M. Ronot,et al.  Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[3]  V. Vilgrain,et al.  Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma , 2006, The British journal of surgery.

[4]  Olivier Ernst,et al.  Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. , 2007, Journal of the American College of Surgeons.

[5]  D. Samuel,et al.  Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? , 2015, Journal of hepatology.

[6]  K. Sung,et al.  Ischemic Bile Duct Injury as a Serious Complication After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma , 2001, Journal of clinical gastroenterology.

[7]  T. Baumert,et al.  Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature. , 2016, Minerva chirurgica.

[8]  C. Gonçalves,et al.  [Hepatocellular carcinoma]. , 1988, Arquivos de gastroenterologia.

[9]  R. Lencioni,et al.  Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data , 2016, Hepatology.

[10]  Yanming Zhou,et al.  Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma , 2013, BMC Gastroenterology.

[11]  Fan Wu,et al.  Solitary Large Hepatocellular Carcinoma: A Specific Subtype of Hepatocellular Carcinoma With Good Outcome After Hepatic Resection , 2009, Annals of surgery.

[12]  R. Hirose,et al.  Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria , 2015, Hepatology.

[13]  H. Bismuth,et al.  Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver , 2000, Annals of surgery.

[14]  V. Vilgrain,et al.  Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial , 2003, Annals of surgery.

[15]  H. Bismuth,et al.  Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. , 1997, Annals of surgery.

[16]  T. Gamblin,et al.  Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis. , 2015, Surgical oncology clinics of North America.

[17]  A. Rademaker,et al.  Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[18]  O. Farges,et al.  The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.

[19]  L. Leong,et al.  Liver abscess as a complication of hepatic transarterial chemoembolization: a case report, literature review, and clinical recommendations. , 2009, Gastrointestinal cancer research : GCR.

[20]  F. Roudot-thoraval,et al.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.

[21]  S. Zangan,et al.  Hepatocellular Carcinoma Rupture Following Transarterial Chemoembolization , 2015, Seminars in Interventional Radiology.

[22]  E. Benchimol,et al.  Predictive models of disease burden at diagnosis in persons with adult-onset ulcerative colitis using health administrative data , 2019, BMC Gastroenterology.

[23]  W. Lau,et al.  A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma , 2009, Annals of surgery.

[24]  M. Makuuchi,et al.  Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. , 2004, Archives of surgery.

[25]  M. Schwartz,et al.  Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. , 2002, The Lancet. Oncology.

[26]  L. Henry,et al.  Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up , 2015, Annals of Surgical Oncology.

[27]  F. P'eng,et al.  Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal , 1995, The British journal of surgery.

[28]  H. Hasegawa,et al.  A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma , 1996, Japanese journal of cancer research : Gann.